// App-Quantinova.ai

11002 : GEIS-21: A multicentric phase II study of intensive chemotherapy including gemcitabine/docetaxel for the treatment of Ewing sarcoma of children and adults: A report from the Spanish Group of Sarcoma Investigation (GEIS).

Researchers

Presenter

  • Jaume Mora

Principal Investigators

  • Alicia Castaneda

  • Essy Madariegue

  • Antonio Lopez-Pousa

  • Claudia Maria Valverde

  • Javier Martin Broto

  • Xavier Garcia del Muro

  • Javier Martinez Trufero

  • Josefina Cruz

  • Joan Maurel

  • Maria Angeles Vaz

  • Sara Perez-Jaume

  • Enrique Alava

  • Carmen de Torres

Medical Centers

  • Hospital Sant Joan de Deu de Barcelona, Barcelona, Spain

  • Hospital Sant Joan de Deu de Barcelona, Barcelona, Spain

  • Hospital De Sant Pau, Barcelona, Spain

  • Pathology Department, Vall d'Hebron University Hospital, Barcelona, Spain

  • Virgen del Rocio University Hospital, Seville, Spain

  • Institut Catala d'Oncologia, l'Hospitalet de Llobregat, Barcelona, Spain

  • Medical Oncology Department, Miguel Servet University Hospital, Zaragoza, Spain

  • Hospital Universitario de Canarias, Santa Cruz De Tenerife, Spain

  • Hospital Clinic Barcelona, Barcelona, Spain

  • Hospital Ramon y Cajal, Madrid, Spain

  • Hospital Virgen del Rocio, Sevilla, Spain

Locations

  • Spain

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Ewing's sarcoma

Biomarkers

  • EWS RNA Binding Protein 1

Drug/Treatment

  • Gemcitabine

  • Docetaxel

Outcome

  • N/A

Study Design

  • Randomized

  • Multicenteric

  • Prospective

Phase

  • II

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved